Concepedia

Kaitlin J. Devine

KJ

6

Publications

293

Citations

6

H-Index

2020

Active since

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

Parker Institute for Cancer Immunotherapy

Kaitlin J. Devine is an author at Children's Hospital of Philadelphia specializing in health sciences, cellular therapies, and radiation oncology.

ORCID

Top concepts

Publications per year

2020–2024

6

Publications

6

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Allison Barz Leahy, Haley Newman, Yimei Li et al. · The Lancet Haematology · 2021 · 114 citations · Full text

, , +8

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Allison Barz Leahy, Kaitlin J. Devine, Yimei Li et al. · Blood · 2021 · 108 citations · Full text

Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia

Regina M. Myers, Kaitlin J. Devine, Yimei Li et al. · Blood Advances · 2024 · 23 citations · Full text

CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).

Haley Newman, Allison Emily Barz Leahy, Yimei Li et al. · Journal of Clinical Oncology · 2020 · 18 citations

, , +19

Outcomes after Reinfusion of CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Regina M. Myers, Kaitlin J. Devine, Yimei Li et al. · Blood · 2021 · 18 citations

Rows per page

1–5 of 6